For list of the VISTA Collaborators, please see the Acknowledgements below.
Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?
Article first published online: 19 JUL 2012
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization
International Journal of Stroke
Volume 8, Issue 8, pages 652–656, December 2013
How to Cite
Hajjar, K., Fulton, R. L., Diener, H.-C., Lees, K. R., the VISTA Collaborators (2013), Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?. International Journal of Stroke, 8: 652–656. doi: 10.1111/j.1747-4949.2012.00848.x
Conflict of interest: KH reports fees or expenses from Boehringer Ingelheim, D-Pharm, and Lundbeck. RLF declares no conflicts of interest. HCD reports received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from Abbott, Allergan, AstraZeneca, Bayer Vital, BMS, Boehringer Ingelheim, CoAxia, Daichii-Sankyo, D-Pharm, EV3, Fresenius, GlaxoSmithKline, Janssen Cilag, Knoll, MSD, Medtronic, MindFrame, Neurobiological Technologies, Novartis, Novo-Nordisk, Paion, Parke-Davis, Pfizer, Sanofi-Aventis, Schering-Plough, Servier, Solvay, Thrombogenics, Wyeth, and Yamanouchi. Financial support for research projects was provided by Astra/Zeneca, GSK, Boehringer Ingelheim, Lundbeck, Novartis, Janssen-Cilag, Sanofi-Aventis, Syngis and Talecris. The Department of Neurology at the University Duisburg-Essen received research grants from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, NIH, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. HCD has no ownership interest and does not own stocks of any pharmaceutical company. HCD served as editor of Aktuelle Neurologie, Arzneimitteltherapie, Kopfschmerznews, Stroke News, and the Treatment Guidelines of the German Neurological Society, as coeditor of Cephalalgia and on the editorial board of Lancet Neurology, European Neurology and Cerebrovascular Disorders. KRL reports fees or expenses from Archemix, American Stroke Association, Astellas, Asubio, Bayer, Boehringer Ingelheim, Co-Axia, D-Pharm, EVER, Ferrer, GlaxoSmithKline, infill, Johnson & Johnson, Lundbeck, Merck Sharpe and Dhome, Mitsubishi, Photothera, Quintiles, Sanofi-Aventis, Servier, Solvay, Talecris, and Wyeth.
Funding: VISTA has received financial support from the European Stroke Organisation in the form of an unrestricted grant and contributions toward data extraction and capacity building from the Universities of Glasgow, California San Diego, Nottingham, Edmonton, Calgary, Texas, and Massachusetts; from commercial groups including Brainsgate, Novartis, Boehringer Ingelheim, and the Vertical Group; and from grant agencies and charities including the UK Stroke Association. KH is supported by an educational grant from the European Stroke Organisation for young scientists and physicians. RFL was partly funded by a Research Scholarship from Wyeth and Johnson & Johnson.
- Issue published online: 25 NOV 2013
- Article first published online: 19 JUL 2012
- European Stroke Organisation
- Boehringer Ingelheim
- Vertical Group
- UK Stroke Association
- Wyeth and Johnson & Johnson
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.